Press releases
-
-
Internal link ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Global Life Sciences Conference
-
-
Internal link ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome
-
Internal link ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10
-
Internal link ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference
-
-
-
-
-
-
Internal link ProQR to Participate in Upcoming Investor Conferences
-
-
Internal link ProQR Strengthens Scientific Advisory Board with Leaders in Inherited Retinal Disease and RNA Therapy
-
Internal link ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures
-
-
-
-
Internal link ProQR Announces Annual Meeting of Shareholders
-
-
-
Internal link ProQR to Present Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome
-
Internal link ProQR Announces Fourth Quarter and Full Year 2019 Results and Provides Business Update
-
-